Company intelligence / Profile preview

Fiterman Pharma

Iași, Iași, Romania

Ownership: Private
Development stage: Other

Overview

Fiterman Pharma has over three decades of experience as a Romanian pharmaceutical manufacturer. It offers more than 250 products across medicines, medical devices, food supplements, and dermatocosmetics. The company maintains GMP certification since at least 2004 and ISO certifications for quality management. In May 2022 it divested its leading Uractiv urinary tract health portfolio to Sun Pharmaceutical’s Terapia subsidiary. The company remains active with a broad commercial product range.

Therapeutic areas: NephrologyOther
Modalities: Small moleculeBiologicDevicePeptidesProtein
Industry: Biotech

Partnerships

Sun Pharmaceutical Industries Limited/Terapia S.A.

Beyond the preview

Go deeper on Fiterman Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fiterman Pharma.

Explore the full profile